Diabetes Annual 2002
CRC Press (Verlag)
978-1-84184-038-3 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
The incidence of diabetes is increasing in the general population. Recent pharmaceutical developments with the glitazones coupled with intense media attention on the control of type 2 diabetes has lead to a wealth of recent research. The author has assembled an internationally renowned team to examine and assess current issues in diabetes.
[BSc MD FRCP] - Professor of Medicine, Department of Medicine, Division of Medical Sciences
1. Diabetes - Epidemiology, Classification and New Diagnostic Criteria - Implications for Clinical Practice? 2. Diabetes and Obesity - What is the Relationship to Cardiovascular Disease? 3. Diabetes and Hypertension - An Evidence Base for Treatment? 4. Diabetes and Dyslipidemia - An Evidence Base for Treatment? 5. How is Microvascular Disease Best Prevented/Treated? 6. Can Knowledge of Pathogenesis and Pathophysiology of Type 2 Diabetes Help in New Approaches to Drug Therapy? 7. What is the Role of the Thiazolidinediones (Glitazones) in Clinical Practice? 8. What is the Role of Designer Insulins (Insulin Analogues) in Diabetic Practice? 9. What are the Long Term Consequences of Hypoglycemia? 10. Erectile Dysfunction - A Highly Treatable Condition?
Erscheint lt. Verlag | 7.2.2002 |
---|---|
Verlagsort | London |
Sprache | englisch |
Maße | 156 x 234 mm |
Gewicht | 649 g |
Themenwelt | Schulbuch / Wörterbuch ► Lexikon / Chroniken |
Medizinische Fachgebiete ► Innere Medizin ► Diabetologie | |
ISBN-10 | 1-84184-038-6 / 1841840386 |
ISBN-13 | 978-1-84184-038-3 / 9781841840383 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich